Ivermectin in Parasitology Research: Mechanisms and Emerging
2026-06-03
Explore the scientific mechanisms and research applications of Ivermectin, a leading broad-spectrum anti-parasitic agent. This article offers a deeper analysis of its molecular action, quality control, and implications for drug development, setting it apart from recent studies on tumor biology.
Moxidectin: Bridging Parasitic Control and Antifungal Synerg
2026-06-02
Explore how moxidectin, a macrocyclic lactone anthelmintic, is redefining the antifungal landscape by potentiating polyene therapies against Candida albicans. Integrating mechanistic insight, translational protocol guidance, and a strategic vision for cross-domain innovation, this article empowers researchers navigating the frontiers of drug repurposing and combination therapeutics.
Moxidectin (SKU B3611): Reliable Anthelmintic for Antifungal
2026-06-02
This article explores how Moxidectin (SKU B3611) addresses key laboratory challenges in cell viability and antifungal synergy assays. With evidence-backed analysis, it guides researchers in optimizing protocols for parasitic worm control and emerging antifungal applications, emphasizing reproducibility, quality, and practical workflow gains.
ECL Western Blotting Substrate: Technical Workflow Guidance
2026-06-01
ECL Western Blotting Substrate (SKU K2187) is designed for sensitive, nonradioactive detection of horseradish peroxidase (HRP) in chemiluminescent Western blot workflows. It effectively addresses the need for high signal-to-noise protein detection, but should not be used in fluorescent or radioisotopic assays.
7-AAD Cell Viability Assay Kit: Optimizing Precision in Flow
2026-06-01
Discover how the 7-AAD Cell Viability Assay Kit advances precise necrosis and apoptosis detection in complex immunotherapy research. This article explores the scientific rationale, comparative benefits, and actionable protocol insights for leveraging 7-amino actinomycin D assays in high-demand cytometric workflows.
VER 155008: Advanced HSP 70 Inhibition for Cancer & Phase Se
2026-05-31
Explore how VER 155008, a potent HSP 70 inhibitor, uniquely disrupts molecular chaperones to drive apoptosis and inhibit cancer cell proliferation. This article offers new insights into phase separation biology and practical assay design beyond existing guides.
VX-765: Precision Caspase-1 Inhibition for Inflammation Rese
2026-05-30
VX-765 empowers researchers to dissect caspase-1-dependent inflammation and pyroptosis with unmatched selectivity, supporting reproducible cytokine modulation and cell death assays. Its oral bioavailability and workflow versatility make it a linchpin for studies in autoimmune, infectious, and translational disease models.
Lactobacillus gasseri Enhances Colitis Recovery via E-cadher
2026-05-29
Qian et al. demonstrated that Lactobacillus gasseri ATCC33323 improves colitis outcomes by preserving the intestinal mucosal barrier in a DSS-induced mouse model. The study clarified the mechanistic role of NR1I3-mediated E-cadherin regulation, providing new insights for probiotic-based interventions in IBD.
CPI-613: Transforming Tumor Cell Metabolism Studies in Cance
2026-05-29
CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) enables robust, reproducible disruption of mitochondrial metabolism in tumor models. Discover optimized workflows, troubleshooting strategies, and actionable protocol parameters for apoptosis assays and acute myeloid leukemia research—illuminated by new mechanistic insights into regulated cell death.
Acifran: Precision Agonist for Lipid Metabolism Research
2026-05-28
Acifran empowers researchers to dissect lipid metabolism with precision, leveraging recent breakthroughs in receptor structure and ligand selectivity. With proven reliability in cell-based and structural assays, Acifran accelerates the study of metabolic disorder mechanisms and optimizes lipid signaling workflows.
3-Aminobenzamide (PARP-IN-1): Precision PARP Inhibition in R
2026-05-28
3-Aminobenzamide (PARP-IN-1) empowers researchers to dissect poly (ADP-ribose) polymerase (PARP) biology with high specificity and reproducibility. Its low toxicity and robust inhibition profile make it a tool of choice for studies spanning oxidant injury, endothelial function, and advanced antiviral models.
Moxidectin Elevates Ergosterol to Potentiate Polyene Antifun
2026-05-27
A 2024 study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, synergizes with polyene antifungals by upregulating ergosterol biosynthesis in Candida albicans. This mechanism not only enhances antifungal efficacy but also suggests a promising route for repurposing moxidectin against drug-resistant oral candidiasis.
UBE2F-SAG–Mediated RHEB Neddylation Drives mTORC1 in Liver T
2026-05-27
The referenced study demonstrates that the UBE2F-SAG axis directly neddylates RHEB, promoting mTORC1 activity and aggravating liver tumorigenesis. This mechanistic insight reveals novel post-translational regulation of mTORC1 and potential therapeutic targets for hepatocellular carcinoma.
Dibutyryl-cAMP, Sodium Salt: Applied Protocols for cAMP Sign
2026-05-26
Dibutyryl-cAMP, sodium salt empowers researchers to activate cAMP signaling with precision, unlocking robust experimental control over gene expression, neuroinflammation, and neuronal plasticity. This guide translates the latest evidence and workflow insights into actionable protocols, troubleshooting, and performance benchmarking for advanced signaling studies.
GMDS Drives Core Fucosylation in MYCN-Amplified Neuroblastom
2026-05-26
This study identifies GDP-mannose 4,6-dehydratase (GMDS) as a direct transcriptional target of N-MYC and a key driver of core fucosylation in MYCN-amplified neuroblastoma. The findings reveal that de novo GDP-fucose synthesis is essential for tumor progression, highlighting a metabolic vulnerability with potential therapeutic implications.
467 records 17/32 page Previous Next First page 上5页 1617181920 下5页 Last page